Crewe Advisors’s NuVasive, Inc. NUVA Stock Holding History

Crewe Advisors’s Portfolio NUVA Stock Details NUVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-51	Closed	-$4K	–	256
2019 Q4	$4K	Buy	+51	New	+$3.6K	﹤0.01%	206

Other funds holding NUVA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

ACA

Anchor Capital Advisors Boston, Massachusetts $3.51B AUM 16.99% 1-Year Est. Return

Crewe Advisors's NUVA Position: Q1 2020 in Review

Crewe Advisors sold out of NuVasive, Inc. (NUVA) in Q1 2020, closing a stake of 51 shares — an estimated $4K sold.

Crewe Advisors first reported a position in NUVA in Q4 2019 and held it in 1 quarter. The position peaked at $4K in Q4 2019. 266 funds tracked by Wall St. Rank hold NUVA as of Q1 2020.

Crewe Advisors reported no remaining NuVasive, Inc. position as of Q1 2020 after selling out during the quarter.
Crewe Advisors sold 51 NuVasive, Inc. shares in Q1 2020, an estimated $4K.
Crewe Advisors first reported a position in NuVasive, Inc. in Q4 2019 and held it in 1 quarter.
Crewe Advisors's NuVasive, Inc. position peaked at $4K in Q4 2019.
266 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q1 2020.

Based on Crewe Advisors's 13F filing for Q1 2020, filed 7 May 2020.